Home
Nona Biosciences

三月 2026的Nona Biosciences市场份额分析

Discover Nona Biosciences' pioneering fully human heavy chain only antibodies (HCAb/VHH) Harbour Mice® platform, driving innovation in next-gen therapeutic modalities. Explore how our advanced single-domain antibody technology accelerates the development of bispecifics, ADCs, CAR-T therapies, and more.

行业: 不适用

域nonabio.com

成立年份2022

员工51 - 200

年营收--

Nona Biosciences

Nona Biosciences（包含公司地区分支机构）

nonabio.com

查看更多网站流量和参与度信息

Nona Biosciences热门域名的总访问量

了解Nona Biosciences市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

子公司明细

nonabio.com10K

使用销售情报查看更多信息

Nona Biosciences热门域名的平均访问时长

分析Nona Biosciences参与度指标。

过去 3 个月的平均访问时长

子公司明细

nonabio.com00:00:02

使用销售情报查看更多信息

Nona Biosciences热门域名的平均页面浏览量

了解Nona Biosciences如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

子公司明细

nonabio.com1.34

使用销售情报查看更多信息

Nona Biosciences 排名靠前的竞争对手（按域名）

三月 2026的热门相似网站，按亲和力排名

harbourbiomed.com公司名称Harbour BioMed员工51 - 200总部美国, 马萨诸塞州, Cambridge年营收$25M - $50M总访问量6.3K健康 > 生物科技及制药

Nona Biosciences 采用的主要技术

这些是排名前 Nona Biosciences 的顶级域名所使用的网站技术（按行业分列）

付费广告 (5)

DoubleClick

小部件 (5)

Twemoji

移动设备 (3)

Meta Viewport

转化和分析 (2)

Google Analytics

更多技术

9

查看全部

Nona Biosciences 的新闻与信号

借助 Similarweb 销售信号提醒，每当在目标受众之中出现新的机会或威胁时，您都会收到所识别出购买信号的每日更新。

新闻Nonabio partnered with Link Cell Therapies, Inc on Jan 9th '26.Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery through innovative technology platforms, today announced that it has entered into a multi-target antibody discovery collaboration with Link Cell Therapies.

新闻Valinktx partnered with Nonabio on Dec 17th '25.December 17, 2025 - Cambridge, USA and London, UK - Valink Therapeutics ("Valink"), a private biotechnology company developing next-generation therapeutics with a focus on bispecific antibody-drug conjugates (bsADCs) and complementary modalities, and Nona Biosciences ("Nona"), a global biotechnology company providing integrated solutions for biological drug discovery and development from "Idea to IND" (I to I(R), today announced the formation of a strategic biologics discovery alliance.

新闻Nonabio hired Hongjiang Miao as Chief AI Officer on Dec 4th '25.CAMBRIDGE, Mass., Dec. 3, 2025 /PRNewswire/ - Nona Biosciences ("Nona" or the "Company"), a global biotechnology company providing integrated solutions for biological drug discovery and development from I to I(R)(Idea to IND), today announced the appointment of Dr. Hongjiang Miao as Chief AI Officer.